The U.S. grew a 2.8% annual pace in the third quarter, revised figures showed, and indicated the economy headed into the crucial holiday shopping season with plenty of momentum. The increase in gross ...

A record setting rally for U.S. stocks ahead of Thanksgiving has the blue-chip Dow and S&P 500 on pace for their best month ...

A pre-holiday deluge of economic data, including weekly jobless claims, durable-goods orders and a revised third-quarter gross domestic product reading, did little to move stock-index futures or ...

WW International Inc., the company known as WeightWatchers, announced the departure of its finance chief on Wednesday, the ...

CervoMed shares rose 15% after receiving the Food and Drug Administration's orphan drug designation for neflamapimod, its frontotemporal dementia treatment. Shares were trading around $9.19. The stock ...

With U.S. stock markets set to open in two hours, Nutanix Inc. Cl A (NTNX) was up 5.9% in pre-market trading, and MicroStrategy Inc. (MSTR) was up 5.2%. Back To Top ...

Tuesday's consumer confidence reading from the Conference Board showed that sentiment got a boost following President-elect ...

Shares have been down in 2024, falling about 20% since the beginning of the year and closing on Tuesday at 34.33 Canadian dollars ($24.42). At that price, the value of the shares intended for buyback ...

Kronos Bio said it would cut about 83% of its workforce by the end of the year and named a new interim chief executive, as the company continues to explore strategic options. The San Mateo, Calif., ...

Symbotic reduced its quarterly guidance and said it will need more time to file its annual report after identifying an error in its system revenue recognition. The ...

Outlook Therapeutics will resubmit a biologics license application for its ophthalmic formulation of bevacizumab early next year after the second of two clinical trials missed a key target. The ...